The prevalence and significance of substance use disorders in bipolar type I and II disorder
2007

Substance Use Disorders in Bipolar Disorder

Sample size: 43093 publication Evidence: moderate

Author Information

Author(s): Michael A Cerullo, Stephen M Strakowski

Primary Institution: University of Cincinnati College of Medicine

Hypothesis

The paper aims to systematically review the literature on the epidemiology, outcome, and treatment of patients with bipolar disorder and co-occurring substance use disorders.

Conclusion

Patients with bipolar I and II disorders have a high rate of co-occurring substance use disorders, which negatively impacts their treatment outcomes.

Supporting Evidence

  • The lifetime prevalence of substance use disorders is at least 40% in bipolar I patients.
  • Co-occurring substance use disorders are correlated with negative effects on illness outcomes.
  • There is a lack of treatment research specifically targeting bipolar patients with substance use disorders.

Takeaway

Many people with bipolar disorder also have problems with drugs or alcohol, which makes it harder for them to feel better.

Methodology

The review included relevant studies identified through a comprehensive Medline search and references from selected articles, excluding case reports.

Potential Biases

Many treatment studies were open-label and may not provide reliable evidence for treatment efficacy.

Limitations

The review is limited by the lack of treatment research specifically targeting bipolar patients with co-occurring substance use disorders.

Participant Demographics

The review includes data from various studies with diverse populations, including general population surveys and specific patient groups.

Digital Object Identifier (DOI)

10.1186/1747-597X-2-29

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication